Summary: global partnership this month, revenue in October, and new investor deck has a timeline. They will be putting out Q4 revenue guidance in September, testing their low cost human CGM in Q4, up list to NYSE American in Q1 2023, and have a global launch with the leading animal health company they are partnering with in June of 2023.
News 
Market Data 
Discover 
AI
